All stock lists
Fortress Biotech, Inc. (NASDAQ:FBIO)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
1.89-0.04 (-2.33%)
Insider Score
––Not scored
FBIO Insider Score
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
FBIO Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 18.72 M | 16.04 M | 16.08 M | 17.63 M | 16.41 M | 13.14 M |
| Revenue Growth (YoY) | 14.04 % | 22.06 % | 6.34 % | 20.52 % | 10.18 % | 0.84 % |
| Cost of Revenue | 7.11 M | 7.34 M | 5.44 M | 5.75 M | 4.94 M | 4.79 M |
| Gross Profit | 11.61 M | 8.69 M | 10.64 M | 11.88 M | 11.47 M | 8.35 M |
| SG&A Expense | 20.81 M | 15.89 M | 14.73 M | 17.41 M | 38.76 M | 25.66 M |
| R&D Expense | 805.00 K | 540.00 K | -367.00 K | 208.00 K | 8.13 M | 3.94 M |
| Operating Expenses | 21.61 M | 16.43 M | 15.43 M | 18.69 M | 47.95 M | 30.67 M |
| Operating Income | -10.01 M | -7.74 M | -4.79 M | -6.81 M | -36.47 M | -22.32 M |
| Pretax Income | 900.00 K | 142.29 M | -6.21 M | 8.85 M | -11.65 M | -24.69 M |
| Tax Provision | 298.00 K | 5.13 M | -816.00 K | 26.00 K | 0.00 | 0.00 |
| Net Income | -468.00 K | 110.37 M | -3.94 M | 5.85 M | 15.49 M | -10.58 M |
| EPS (Basic) | -0.08 | 3.44 | -0.22 | 0.13 | 0.50 | -0.48 |
| EPS (Diluted) | -0.08 | 2.82 | -0.17 | 0.11 | 0.45 | -0.48 |
| Shares Outstanding | 31.67 M | 31.54 M | 27.90 M | 27.24 M | 26.88 M | 26.45 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
